Cargando…
Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer
Background: Chimeric antigen receptor (CAR)-modified T cells have successfully harnessed T cell immunity against malignancies, but they are by no means the only cell therapies in development for cancer. Main Text Summary: Systemic immunity is thought to play a key role in combatting neoplastic disea...
Autores principales: | Patel, Shabnum, Burga, Rachel A., Powell, Allison B., Chorvinsky, Elizabeth A., Hoq, Nia, McCormack, Sarah E., Van Pelt, Stacey N., Hanley, Patrick J., Cruz, Conrad Russell Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467966/ https://www.ncbi.nlm.nih.gov/pubmed/31024832 http://dx.doi.org/10.3389/fonc.2019.00196 |
Ejemplares similares
-
Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization
por: Powell, Allison B., et al.
Publicado: (2019) -
First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G
por: Anna, François, et al.
Publicado: (2021) -
Adoptive Immunotherapy beyond CAR T-Cells
por: Titov, Aleksei, et al.
Publicado: (2021) -
A New Method for Reactivating and Expanding T Cells Specific for Rhizopus oryzae
por: Castillo, Paul, et al.
Publicado: (2018) -
Mesothelin: An Immunotherapeutic Target beyond Solid Tumors
por: Faust, Joshua R., et al.
Publicado: (2022)